| Year |
Citation |
Score |
| 2022 |
Rastogi S, Briken V. Interaction of Mycobacteria With Host Cell Inflammasomes. Frontiers in Immunology. 13: 791136. PMID 35237260 DOI: 10.3389/fimmu.2022.791136 |
0.415 |
|
| 2021 |
Rastogi S, Ellinwood S, Augenstreich J, Mayer-Barber KD, Briken V. Mycobacterium tuberculosis inhibits the NLRP3 inflammasome activation via its phosphokinase PknF. Plos Pathogens. 17: e1009712. PMID 34324582 DOI: 10.1371/journal.ppat.1009712 |
0.347 |
|
| 2020 |
Augenstreich J, Briken V. Host Cell Targets of Released Lipid and Secreted Protein Effectors of . Frontiers in Cellular and Infection Microbiology. 10: 595029. PMID 33194845 DOI: 10.3389/fcimb.2020.595029 |
0.384 |
|
| 2019 |
Behar SM, Briken V. Apoptosis inhibition by intracellular bacteria and its consequence on host immunity. Current Opinion in Immunology. 60: 103-110. PMID 31228759 DOI: 10.1016/J.Coi.2019.05.007 |
0.508 |
|
| 2019 |
Banks DA, Ahlbrand SE, Hughitt VK, Shah S, Mayer-Barber KD, Vogel SN, El-Sayed NM, Briken V. Inhibits Autocrine Type I IFN Signaling to Increase Intracellular Survival. Journal of Immunology (Baltimore, Md. : 1950). PMID 30833347 DOI: 10.4049/Jimmunol.1801303 |
0.393 |
|
| 2017 |
Quigley J, Hughitt VK, Velikovsky CA, Mariuzza RA, El-Sayed NM, Briken V. The Cell Wall Lipid PDIM Contributes to Phagosomal Escape and Host Cell Exit of Mycobacterium tuberculosis. Mbio. 8. PMID 28270579 DOI: 10.1128/Mbio.00148-17 |
0.504 |
|
| 2016 |
Shah S, Briken V. Modular Organization of the ESX-5 Secretion System in Mycobacterium tuberculosis. Frontiers in Cellular and Infection Microbiology. 6: 49. PMID 27200304 DOI: 10.3389/Fcimb.2016.00049 |
0.386 |
|
| 2016 |
Srinivasan L, Gurses SA, Hurley BE, Miller JL, Karakousis PC, Briken V. Identification of a Transcription Factor That Regulates Host Cell Exit and Virulence of Mycobacterium tuberculosis. Plos Pathogens. 12: e1005652. PMID 27191591 DOI: 10.1371/Journal.Ppat.1005652 |
0.674 |
|
| 2016 |
Hettiarachchi G, Samanta SK, Falcinelli S, Zhang B, Moncelet D, Isaacs L, Briken V. Acyclic cucurbit[n]uril-type molecular container enables systemic delivery of effective doses of albendazole for treatment of SK-OV-3 xenograft tumors. Molecular Pharmaceutics. PMID 26756920 DOI: 10.1021/Acs.Molpharmaceut.5B00723 |
0.341 |
|
| 2015 |
Vural A, Al-Khodor S, Cheung GY, Shi CS, Srinivasan L, McQuiston TJ, Hwang IY, Yeh AJ, Blumer JB, Briken V, Williamson PR, Otto M, Fraser ID, Kehrl JH. Activator of G-Protein Signaling 3-Induced Lysosomal Biogenesis Limits Macrophage Intracellular Bacterial Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 26667172 DOI: 10.4049/Jimmunol.1501595 |
0.422 |
|
| 2015 |
Shah S, Cannon JR, Fenselau C, Briken V. A duplicated ESAT-6 region of ESX-5 is involved in protein export and virulence of mycobacteria. Infection and Immunity. PMID 26303392 DOI: 10.1128/Iai.00827-15 |
0.397 |
|
| 2014 |
Srinivasan L, Ahlbrand S, Briken V. Interaction of Mycobacterium tuberculosis with host cell death pathways. Cold Spring Harbor Perspectives in Medicine. 4. PMID 24968864 DOI: 10.1101/Cshperspect.A022459 |
0.508 |
|
| 2013 |
Briken V, Ahlbrand SE, Shah S. Mycobacterium tuberculosis and the host cell inflammasome: a complex relationship. Frontiers in Cellular and Infection Microbiology. 3: 62. PMID 24130966 DOI: 10.3389/Fcimb.2013.00062 |
0.445 |
|
| 2013 |
Shah S, Bohsali A, Ahlbrand SE, Srinivasan L, Rathinam VA, Vogel SN, Fitzgerald KA, Sutterwala FS, Briken V. Cutting edge: Mycobacterium tuberculosis but not nonvirulent mycobacteria inhibits IFN-β and AIM2 inflammasome-dependent IL-1β production via its ESX-1 secretion system. Journal of Immunology (Baltimore, Md. : 1950). 191: 3514-8. PMID 23997220 DOI: 10.4049/Jimmunol.1301331 |
0.476 |
|
| 2013 |
Briken V. Mycobacterium tuberculosis genes involved in regulation of host cell death. Advances in Experimental Medicine and Biology. 783: 93-102. PMID 23468105 DOI: 10.1007/978-1-4614-6111-1_5 |
0.521 |
|
| 2012 |
Briken V. "With a little help from my friends": efferocytosis as an antimicrobial mechanism. Cell Host & Microbe. 12: 261-3. PMID 22980322 DOI: 10.1016/J.Chom.2012.08.008 |
0.345 |
|
| 2012 |
Abdalla H, Srinivasan L, Shah S, Mayer-Barber KD, Sher A, Sutterwala FS, Briken V. Mycobacterium tuberculosis infection of dendritic cells leads to partially caspase-1/11-independent IL-1β and IL-18 secretion but not to pyroptosis. Plos One. 7: e40722. PMID 22911706 DOI: 10.1371/Journal.Pone.0040722 |
0.373 |
|
| 2012 |
Blomgran R, Desvignes L, Briken V, Ernst JD. Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host & Microbe. 11: 81-90. PMID 22264515 DOI: 10.1016/J.Chom.2011.11.012 |
0.478 |
|
| 2011 |
Briken V, Mosser DM. Editorial: switching on arginase in M2 macrophages. Journal of Leukocyte Biology. 90: 839-41. PMID 22045920 DOI: 10.1189/Jlb.0411203 |
0.328 |
|
| 2010 |
Bohsali A, Abdalla H, Velmurugan K, Briken V. The non-pathogenic mycobacteria M. smegmatis and M. fortuitum induce rapid host cell apoptosis via a caspase-3 and TNF dependent pathway. Bmc Microbiology. 10: 237. PMID 20831789 DOI: 10.1186/1471-2180-10-237 |
0.512 |
|
| 2010 |
Hettiarachchi G, Nguyen D, Wu J, Lucas D, Ma D, Isaacs L, Briken V. Toxicology and drug delivery by cucurbit[n]uril type molecular containers. Plos One. 5: e10514. PMID 20463906 DOI: 10.1371/Journal.Pone.0010514 |
0.343 |
|
| 2010 |
Miller JL, Velmurugan K, Cowan MJ, Briken V. The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-alpha-mediated host cell apoptosis. Plos Pathogens. 6: e1000864. PMID 20421951 DOI: 10.1371/Journal.Ppat.1000864 |
0.519 |
|
| 2009 |
Van Rhijn I, Young DC, De Jong A, Vazquez J, Cheng TY, Talekar R, Barral DC, Barral D, León L, Brenner MB, Katz JT, Riese R, Ruprecht RM, O'Connor PB, Costello CE, ... ... Briken V, et al. CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids. The Journal of Experimental Medicine. 206: 1409-22. PMID 19468063 DOI: 10.1084/Jem.20082480 |
0.324 |
|
| 2008 |
Briken V, Miller JL. Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis. Future Microbiology. 3: 415-22. PMID 18651813 DOI: 10.2217/17460913.3.4.415 |
0.538 |
|
| 2008 |
Briken V. Molecular mechanisms of host-pathogen interactions and their potential for the discovery of new drug targets. Current Drug Targets. 9: 150-7. PMID 18288966 DOI: 10.2174/138945008783502449 |
0.42 |
|
| 2007 |
Velmurugan K, Chen B, Miller JL, Azogue S, Gurses S, Hsu T, Glickman M, Jacobs WR, Porcelli SA, Briken V. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. Plos Pathogens. 3: e110. PMID 17658950 DOI: 10.1371/Journal.Ppat.0030110 |
0.672 |
|
| 2004 |
Matsunaga I, Bhatt A, Young DC, Cheng TY, Eyles SJ, Besra GS, Briken V, Porcelli SA, Costello CE, Jacobs WR, Moody DB. Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. The Journal of Experimental Medicine. 200: 1559-69. PMID 15611286 DOI: 10.1084/Jem.20041429 |
0.422 |
|
| 2004 |
Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Molecular Microbiology. 53: 391-403. PMID 15228522 DOI: 10.1111/J.1365-2958.2004.04183.X |
0.493 |
|
| 2004 |
Dao DN, Kremer L, Guérardel Y, Molano A, Jacobs WR, Porcelli SA, Briken V. Mycobacterium tuberculosis Lipomannan Induces Apoptosis and Interleukin-12 Production in Macrophages Infection and Immunity. 72: 2067-2074. PMID 15039328 DOI: 10.1128/Iai.72.4.2067-2074.2004 |
0.452 |
|
| 2003 |
Guérardel Y, Maes E, Briken V, Chirat F, Leroy Y, Locht C, Strecker G, Kremer L. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. The Journal of Biological Chemistry. 278: 36637-51. PMID 12829695 DOI: 10.1074/Jbc.M305427200 |
0.463 |
|
| 2002 |
Moody DB, Briken V, Cheng TY, Roura-Mir C, Guy MR, Geho DH, Tykocinski ML, Besra GS, Porcelli SA. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nature Immunology. 3: 435-42. PMID 11938350 DOI: 10.1038/Ni780 |
0.333 |
|
| 2002 |
Lankar D, Vincent-Schneider H, Briken V, Yokozeki T, Raposo G, Bonnerot C. Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation. The Journal of Experimental Medicine. 195: 461-72. PMID 11854359 DOI: 10.1084/Jem.20011543 |
0.329 |
|
| 2002 |
Briken V, Jackman RM, Dasgupta S, Hoening S, Porcelli SA. Intracellular trafficking pathway of newly synthesized CD1b molecules Embo Journal. 21: 825-834. PMID 11847129 DOI: 10.1093/Emboj/21.4.825 |
0.316 |
|
| 2000 |
Briken V, Jackman RM, Watts GFM, Rogers RA, Porcelli SA. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens Journal of Experimental Medicine. 192: 281-287. PMID 10899914 DOI: 10.1084/Jem.192.2.281 |
0.382 |
|
| 1998 |
Lankar D, Briken V, Adler K, Weiser P, Cassard S, Blank U, Viguier M, Bonnerot C. Syk tyrosine kinase and B cell antigen receptor (BCR) immunoglobulin-α subunit determine BCR-mediated major histocompatibility complex class II- restricted antigen presentation Journal of Experimental Medicine. 188: 819-831. PMID 9730884 DOI: 10.1084/Jem.188.5.819 |
0.306 |
|
| 1998 |
Bonnerot C, Briken V, Brachet V, Lankar D, Cassard S, Jabri B, Amigorena S. syk protein tyrosine kinase regulates Fc receptor γ-chain-mediated transport to lysosomes Embo Journal. 17: 4606-4616. PMID 9707420 DOI: 10.1093/Emboj/17.16.4606 |
0.349 |
|
| 1997 |
Bonnerot C, Briken V, Amigorena S. Intracellular signaling and endosomal trafficking of immunoreceptors: Shared effectors underlying MHC class II-restricted antigen presentation Immunology Letters. 57: 1-4. PMID 9232416 DOI: 10.1016/S0165-2478(97)00054-0 |
0.353 |
|
| 1995 |
Briken V, Ruffner H, Schultz U, Schwarz A, Reis LFL, Strehlow I, Decker T, Staeheli P. Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon Molecular and Cellular Biology. 15: 975-982. PMID 7823961 DOI: 10.1128/Mcb.15.2.975 |
0.318 |
|
| Show low-probability matches. |